Registry for Organ Transplants from COVID Positive Donors
Immune Registry for Organ Transplantation From COVID Positive Donors.
This study is trying to see how well organ transplants from COVID-positive donors work compared to those from COVID-negative donors for people who receive them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Virginia Commonwealth University Academic / other |
| Locations | 1 site (Richmond, Virginia) |
| Trial ID | NCT05595837 on ClinicalTrials.gov |
What this trial studies
This study aims to collect and analyze data from solid organ transplant recipients who received organs from COVID-19 infected donors, comparing their outcomes to those who received organs from COVID-19 negative donors. Researchers will gather information from standard clinical practices, including donor and recipient medical histories, to assess short-term and long-term clinical outcomes. The data will be securely stored in a registry to facilitate future research on organ transplantation and COVID-19. This observational study will help advance understanding of the implications of using organs from COVID-positive donors.
Who should consider this trial
Good fit: Ideal candidates for this study are adult solid organ transplant recipients over 18 years old.
Not a fit: Patients who are unable to provide informed consent or are incarcerated will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide critical insights into the safety and efficacy of organ transplants from COVID-positive donors, potentially expanding the donor pool.
How similar studies have performed: While there may be limited data on this specific approach, the study builds on existing knowledge regarding organ transplantation and infectious disease management, suggesting potential for meaningful insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: - Adult (\>18 years old) male and female solid organ transplant recipients Exclusion Criteria: * Absence of informed consent for the clinical protocol and the registry. * Prisoners will be excluded from the study.
Where this trial is running
Richmond, Virginia
- Virginia Commonwealth University — Richmond, Virginia, United States (Recruiting)
Study contacts
- Principal investigator: Ambreen Azhar, MD — Virginia Commonwealth University
- Study coordinator: Ambreen Azhar, MD
- Email: ambreen.azhar@vcuhealth.org
- Phone: 804-828-4104
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.